Published in Liver Cancer on April 08, 2015
Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology. PLoS One (2016) 0.75
Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma. Liver Cancer (2015) 0.75
Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma. Hepatoma Res (2017) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis (2010) 9.73
Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol (2008) 5.24
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol (2009) 4.82
Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg (2000) 3.97
Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology (2005) 3.26
Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am (2006) 2.32
Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology (1993) 2.30
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2005) 1.89
Local-regional treatment of hepatocellular carcinoma. Radiology (2012) 1.78
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology (1987) 1.73
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl (2004) 1.72
Hepatocellular carcinoma: current surgical management. Gastroenterology (2004) 1.66
Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer (2012) 1.47
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology (1985) 1.46
The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation? J BUON (2014) 1.44
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer (2002) 1.43
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer (2014) 1.35
Chemoembolization for hepatocellular carcinoma. Semin Oncol (2012) 1.23
Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res (2003) 1.23
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version). Hepatol Res (2010) 1.22
Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol (2011) 1.21
Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology (2010) 1.21
Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer (2013) 1.21
Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging (2001) 1.16
Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol (2001) 1.15
Diffusion weighted imaging in the liver. World J Gastroenterol (2010) 1.15
Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology (2010) 1.14
Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol (2003) 1.13
How to define transarterial chemoembolization failure or refractoriness: a European perspective. Liver Cancer (2014) 1.10
Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol (2003) 1.09
Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics (2003) 1.05
A worldwide survey of the current daily practice in liver surgery. Liver Cancer (2013) 1.04
Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol (2005) 1.04
Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography. Oncology (2008) 1.03
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.02
Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. Liver Cancer (2012) 1.02
Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective. Jpn J Clin Oncol (2012) 1.02
Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. Liver Cancer (2014) 1.01
Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging (2008) 1.00
Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol (2004) 0.98
Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology (2013) 0.98
Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J Gastroenterol (2014) 0.97
Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol (2011) 0.97
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol (2006) 0.97
Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol (1997) 0.93
Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy. J Hepatobiliary Pancreat Sci (2009) 0.90
Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl (2004) 0.89
Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma. Am J Gastroenterol (2011) 0.88
Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment. Indian J Radiol Imaging (2013) 0.88
Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR Am J Roentgenol (2003) 0.86
Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology. J Comput Assist Tomogr (1995) 0.85
Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging (2015) 0.85
Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol (2010) 0.82
Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology (2013) 0.82
Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy. AJR Am J Roentgenol (2013) 0.81
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol (2009) 0.80
Adverse reactions to ultrasound contrast agents: is the risk worth the benefit? Eur J Echocardiogr (2005) 0.79
What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology (2007) 0.79
Clinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions. Liver Cancer (2012) 0.79
Risk factors for adverse reactions from contrast agents for computed tomography. BMC Med Inform Decis Mak (2013) 0.79
Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging (2008) 0.78
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer (2015) 0.95
Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver (2012) 0.93
Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography. Liver Cancer (2014) 0.88
Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications. Liver Cancer (2014) 0.84